Douglas Russo
5PUBLICATIONS
88CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (5)
Sort by Publication Date:
|Feb 05, 2025
A Phase II Study of Abemaciclib for Patients with Retinoblastoma-Positive, Metastatic Triple-Negative Breast Cancer.Shom Goel, Bojana Jovanović, Xiangying Chu
|Jun 08, 2024
Pure estrogen receptor antagonists potentiate capecitabine activity in ESR1-mutant breast cancer.Albert Grinshpun, Douglas Russo, Wen Ma
|Feb 21, 2024
Selective CDK7 Inhibition Suppresses Cell Cycle Progression and MYC Signaling While Enhancing Apoptosis in Therapy-resistant Estrogen Receptor-positive Breast Cancer.Cristina Guarducci, Agostina Nardone, Douglas Russo
|Jul 14, 2023
Endocrine Therapy Synergizes with SMAC Mimetics to Potentiate Antigen Presentation and Tumor Regression in Hormone Receptor-Positive Breast Cancer.Francisco Hermida-Prado, Yingtian Xie, Shira Sherman
|Oct 10, 2022
Clinical Efficacy and Whole-Exome Sequencing of Liquid Biopsies in a Phase IB/II Study of Bazedoxifene and Palbociclib in Advanced Hormone Receptor-Positive Breast Cancer.Junko Tsuji, Tianyu Li, Albert Grinshpun
Pageof 1
Frequent Collaborators
5 joint publications
Rinath Jeselsohn
3 joint publications
Albert Grinshpun
3 joint publications
Agostina Nardone
3 joint publications
Cristina Guarducci
3 joint publications
Sara M Tolaney
3 joint publications
Nabihah Tayob
2 joint publications
Francisco Hermida-Prado
2 joint publications
Avery Feit
2 joint publications
Shira Sherman
2 joint publications
Zsuzsanna Nagy
